Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework

Oliver, Sara E.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework

[PDF-4.55 MB]

English

Details Related Documents You May Also Like

Details:

Personal Author:

Oliver, Sara E.
Corporate Authors:

United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group.
Conference Authors:

United States. Advisory Committee on Immunization Practices. Meeting (2021 Feb. April 14: Atlanta, GA)
Description:

During the ACIP meeting, the numbers presented were risks and benefits per two million vaccine doses; numbers have been updated here to reflect risks and benefits per one million vaccine doses.

06-COVID-Oliver-508.pdf
Subjects:

[+]

Coronavirus Infections/prevention & Control COVID-19 Vaccines/adverse Effects Patient Safety Safety-Based Drug Withdrawals Thrombocytopenia Thrombosis
Series:

ACIP meeting COVID-19 Vaccines
Document Type:

Presentation
Name as Subject:

ACIP meeting: 2021 Apr. 23 ; Janssen COVID-19 Vaccine ; Coronavirus Infections/prevention & control ; COVID-19 Vaccines/adverse effects ; Patient Safety ; ... More +

ACIP meeting: 2021 Apr. 23 ; Janssen COVID-19 Vaccine ; Coronavirus Infections/prevention & control ; COVID-19 Vaccines/adverse effects ; Patient Safety ; Safety-Based Drug Withdrawals ; Thrombocytopenia ; Thrombosis ; ACIP meeting: 2021 Apr. 23 ; Janssen COVID-19 Vaccine ; Coronavirus Infections/prevention & control ; COVID-19 Vaccines/adverse effects ; Patient Safety ; Safety-Based Drug Withdrawals ; Thrombocytopenia ; Thrombosis Less -
Genre:

Conference Publications
Volume:

202105
Issue:

0100106
Collection(s):

Advisory Committee on Immunization Practices (ACIP)
Main Document Checksum:

[+]

urn:sha256:9eee32cd205e3fa1ae33d33a82460cfb632752396a5793666d1c7d08c7bfa763
Download URL:

https://stacks.cdc.gov/view/cdc/107511/cdc_107511_DS1.pdf
File Type:

No Additional Files

More +

Risk/Benefit assessment of thrombotic thrombocytopenic events after Janssen COVID-19 vaccines : Applying evidence to recommendation framework

Details:

Supporting Files

Related Documents

You May Also Like